(Q36426091)

14 August 2017

Circulating suPAR in two cohorts of primary FSGS. (English)

1 reference

Dagmar-Christiane Fischer

14 August 2017

18

object named as

Dagmar-Christiane Fischer

1 reference

ORCID Public Data File 2021

14 August 2017

1 reference

Debbie S Gipson

16

object named as

Debbie S Gipson

1 reference

14 August 2017

Changli Wei

1

1 reference

14 August 2017

Howard Trachtman

2

1 reference

14 August 2017

Jing Li

3

1 reference

14 August 2017

Chuanhui Dong

4

1 reference

14 August 2017

Aaron L Friedman

5

1 reference

14 August 2017

Jennifer J Gassman

6

1 reference

14 August 2017

June L McMahan

7

1 reference

14 August 2017

Milena Radeva

8

1 reference

14 August 2017

Karsten M Heil

9

1 reference

14 August 2017

Agnes Trautmann

10

1 reference

14 August 2017

Ali Anarat

11

1 reference

14 August 2017

Sevinc Emre

12

1 reference

14 August 2017

Gian M Ghiggeri

13

1 reference

14 August 2017

Fatih Ozaltin

14

1 reference

14 August 2017

Dieter Haffner

15

1 reference

14 August 2017

Frederick Kaskel

17

1 reference

14 August 2017

Franz Schaefer

19

1 reference

14 August 2017

Jochen Reiser

20

1 reference

14 August 2017

PodoNet and FSGS CT Study Consortia

21

1 reference

14 August 2017

8 November 2012

1 reference

Journal of the American Society of Nephrology

14 August 2017

1 reference

14 August 2017

23

1 reference

14 August 2017

12

1 reference

14 August 2017

2051-2059

1 reference

Soluble urokinase receptor and focal segmental glomerulosclerosis

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

Clinical trial of focal segmental glomerulosclerosis in children and young adults

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

Comparison of C-reactive protein and metabolic syndrome as cardiovascular risk factors in African-Americans and European-Americans

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

Focal and segmental glomerulosclerosis: definition and relevance of a partial remission

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

Other immunosuppressive agents for focal segmental glomerulosclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

Focal segmental glomerulosclerosis: pathogenesis and treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

Management of focal segmental glomerulosclerosis: evidence-based recommendations.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

CRP and suPAR are differently related to anthropometry and subclinical organ damage

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

Focal and segmental glomerulosclerosis in children: a longitudinal assessment.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

Sera from patients with collapsing focal segmental glomerulosclerosis increase albumin permeability of isolated glomeruli

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

NPHS2 mutation associated with recurrence of proteinuria after transplantation

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507361

Detection of soluble urokinase receptor by immunoradiometric assay and its application in tumor patients

21 September 2018

1 reference

12 December 2020

Treatment of primary focal segmental glomerulosclerosis

1 reference

12 December 2020

Serial Estimates of Serum Permeability Activity and Clinical Correlates in Patients with Native Kidney Focal Segmental Glomerulosclerosis

1 reference

12 December 2020

Plasma "factors" in recurrent nephrotic syndrome after kidney transplantation: causes or consequences of glomerular injury?

1 reference

12 December 2020

Fetuin-A serum concentrations in healthy children

1 reference

12 December 2020

The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in systemic inflammatory response syndrome

1 reference

12 December 2020

Identifiers

DOI

10.1681/ASN.2012030302

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

23138488

1 reference